MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 27981-27990 Newer>
The Motley Fool
January 9, 2008
Anders Bylund
Dueling Fools: Google Bull Rebuttal The bullish argument about Google is that the company has just begun working towards its goal of shooting for 10% or so of the total global advertising market. mark for My Articles 2584 similar articles
The Motley Fool
January 9, 2008
Rich Duprey
Family Dollar's No Discount Discount chain Family Dollar reports in its first-quarter results that same-store sales fell and theft rose. mark for My Articles 555 similar articles
The Motley Fool
January 9, 2008
Tim Beyers
Can TiVo Play the Video Star? TiVo announces at this year's Consumer Electronics Show that it will enable customers to browse Web video through its players. mark for My Articles 378 similar articles
The Motley Fool
January 9, 2008
Anders Bylund
Microsoft Goes Fishing for Enterprise Search Microsoft agrees to pay about $1.2 billion for Norwegian enterprise search specialist Fast Search and Transfer, as part of their plans to develop a global business unit. mark for My Articles 17 similar articles
The Motley Fool
January 9, 2008
Rick Aristotle Munarriz
Yahoo! Hits Belo the Belt Clip Yahoo! teams up with media giant Belo to offer local news videos on its site. mark for My Articles 1409 similar articles
The Motley Fool
January 9, 2008
Brian Lawler
Checking In on Biogen Biogen Idec presents at the JPMorgan Healthcare Conference, reiterating its long-term guidance of 15% compound annual sales growth and 20% average non-GAAP earnings-per-share growth from 2007 through 2010. mark for My Articles 292 similar articles
The Motley Fool
January 9, 2008
Dave Mock
Sprinting Out of a Jam Struggling carrier Sprint Nextel is speeding ahead with its next-generation broadband wireless initiative called Xohm. mark for My Articles 562 similar articles
The Motley Fool
January 9, 2008
Brian Lawler
Tracking Genzyme The biopharma updates investors on what to expect for 2008. mark for My Articles 97 similar articles
The Motley Fool
January 9, 2008
Chuck Saletta
The Right Way to Be Wrong Since 2008 rolled in, the market has dropped some 5%. Add to that recession fears, further housing troubles, and panicked investors. The beautiful part about panic, though, is that it creates tremendous bargains. mark for My Articles 149 similar articles
The Motley Fool
January 9, 2008
Brian Orelli
Genzyme Buys Into Antisense RNA -- Big Time Genzyme buys a piece of Isis' mipomersen at a wowser of a price. mark for My Articles 149 similar articles
<Older 27981-27990 Newer>    Return to current articles.